| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |